Hi Tony, I agree broadly about dividends and buybacks. Little T has been suggesting it for a while though. Perhaps he is more likely to be within groups that have influence of such matters.
As for expenditure, NEU will have reasonable amount with trials in coming. I was curious how much fanking was available. Just out of curiosity.
If the FDA meetings went as expected and even if not, NeU may well have been able to get accurate costings for the next trials. Due to FDA information.
Which should define if there is spare cash for what Little T would like to see.
Perhaps also, addition development/deals/cash rolling in with ROW territories opening up for Daybue. That havent been made public.
I feel the next updates will open up the pathways and projected cash burn and timelines.
.
Share Price, page-12116
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.27 |
Change
-0.070(0.57%) |
Mkt cap ! $1.568B | |||
| Open | High | Low | Value | Volume |
| $12.30 | $12.40 | $12.16 | $2.116M | 172.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1925 | $12.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.36 | 1035 | 1 |
View Market Depth
| Last trade - 16.10pm 05/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |